Abstract Enterolactone (ENL) is formed by the conversion of dietary precursors like strawberry lignans via the gut microbiota. Urinary concentrations of lignan metabolites are reported to be significantly associated with a lower risk of Type 2 diabetes (T2D). In the present study, antidiabetic effect of ENL and its modes of action were studied in vitro and in vivo employing a rat skeletal muscle-derived cell line, L6 myocytes in culture, and T2D model db/db mice. ENL dose-dependently increased glucose uptake in L6 myotubes under insulin absent condition. This increase by ENL was canceled by compound C, an inhibitor of 5 0 -adenosine monophosphate-activated protein kinase (APMK). Activation (=phosphoryla-tion) of AMPK and translocation of glucose transporter 4 (GLUT4) to plasma membrane in L6 myotubes were demonstrated by Western blotting analyses. Promotion by ENL of GLUT4 translocation to plasma membrane was also visually demonstrated by immunocytochemistry in L6 myoblasts that were transfected with glut4 cDNA-coding vector. T2D model db/db mice were fed the basal 20 % casein diet (20C) or 20C supplemented with ENL (0.001 or 0.01 %) for 6 weeks. Fasting blood glucose (FBG) levels were measured every week and intraperitoneal glucose tolerance test (IPGTT) was conducted. ENL at a higher dose (0.01 % in 20C) suppressed the increases in FBG levels. ENL was also demonstrated to improve the index of insulin resistance (HOMA-IR) and glucose intolerance by IPGTT in db/db mice. From these results, ENL is suggested to be an antidiabetic chemical entity converted from dietary lignans by gut microbiota. 
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Introduction
The mammalian lignans enterolactone (ENL) and enterodiol are commonly found in blood and urine of pigs (Bach Knudsen et al. 2003) and humans (Setchell et al. 2014) . They are formed by the conversion of dietary precursor lignans from, for instance, strawberry (Mazur et al. 2000) and rye (Bach Knudsen et al. 2003) via the intestinal microbiota (Setchell et al. 1981) . ENL has been thought to be the major biologically active lignan, and suggested to be associated with low risk of acute coronary events (Vanharanta et al. 1999 ) and breast cancer ). We have found that ENL more strongly suppresses the proliferation/growth of AH109A hepatoma cells in vitro and in vivo than does its precursor lignan hydroxymatairesinol (Miura et al. 2007) , suggesting that ENL is a chemical entity showing various bioactivities of lignans. Urinary concentrations of lignan metabolites, especially enterolactone, are reported to be significantly associated with a lower risk of Type 2 diabetes (T2D) in humans (Sun et al. 2014 ).
In the present study, antidiabetic effect of ENL and its modes of action were studied both in vitro and in vivo employing rat skeletal muscle-derived L6 myocytes in culture and T2D model db/db mice, respectively. Glucose uptake by L6 myotubes in culture L6 Myoblasts were maintained in DMEM supplemented with 10 % (v/v) FBS, streptomycin (100 lg/ ml), and penicillin G (100 IU/ml) (10 % FBS/DMEM) under atmosphere of 5 % CO 2 /95 % humidified air at 37°C as previously described (Yagasaki et al. 2003) . Effect of ENL on glucose uptake in L6 myotubes was investigated according to the procedure as described previously (Kawano et al. 2009 ) with slight modifications . In brief, L6 myoblasts (5 9 10 4 cells/well) were grown in Nunc 24-place multiwell plates and cultured for 11 days to form myotubes. The myotubes were preincubated for 2 h in Krebs-Henseleit buffer (pH 7.4) containing 0.1 % BSA, 10 mM Hepes and 2 mM sodium pyruvate (KHH buffer). The myotubes were then incubated in KHH buffer (0.4 ml) containing 11 mM glucose in the absence or presence of ENL (0-100 lM) for 4 h. ENL was dissolved in absolute ethanol. The final ethanol concentration in experimental media was 0.1 % (v/v). Glucose concentrations in KHH buffer were determined with a glucose assay kit. The amounts of glucose uptake were calculated from the differences in glucose concentrations between before and after incubation.
Materials and methods

Materials
Western blotting analyses
Western blotting analyses for phosphorylation of 5 0 -adenosine monophosphate-activated protein kinase (AMPK) was performed as described previously (Minakawa et al. 2011; Son et al. 2015) . Briefly, L6 myoblasts (5 9 10 5 cells/dish) were cultured in Nunc 60 mm dishes and grown for 11 days to form myotubes. The myotubes were incubated 2 h in KHH buffer. They were then incubated in KHH buffer containing 11 mM glucose in the absence or presence of ENL for 30, 60, 120 and 240 min. The cell lysates were subjected to Western blotting analyses for AMPK and phospho-AMPK.
From L6 myotubes differentiated in 60 mm dishes and treated with ENL, plasma membrane fractions were obtained by the methods described previously (Nishiumi and Ashida 2007) with slight modifications. Then, Western blotting analyses for GLUT4 and Na ? K ? -ATPase were conducted as described previously (Minakawa et al. 2011 ).
Transfection of HaloTag
Ò -glut4 expression vector (pFN21A-rat glut4) into L6 myoblasts and immunocytochemistry Effect of ENL on GLUT4 translocation to plasma membrane was also examined by the visualizing method according to the procedure previously described (Minakawa et al. 2012) . To transfect the expression vector (HaloTag Ò -glut4 vector), L6 myoblasts (5 9 10 4 cells/well) were cultured in an 8-well chamber slide (Nunc) for immunocytochemistry. To support cell attachment and growth, the 8-well chamber slide was coated with collagen (Nitta Gelatin, Osaka, Japan). After 24 h, at an approximately 60 % confluency, they were transfected with the expression vector or control vector using FuGENE 6 (Roche Diagnostics, IN, USA), according to the manufacturer's instruction. The amount of transfected DNA was 0.2 lg/well. Cells were used for immunocytochemistry 36 h after transfection, using appropriate antibodies and Axiovert 200 M microscope (Carl Zeiss, Oberkochen, Germany), as already mentioned (Minakawa et al. 2012) .
Animal experiments and diets
Animal experiments were conducted in accordance with guidelines established by the Animal Care and Use Committee of Tokyo University of Agriculture and Technology and were approved by this committee (ethics approval number: 22-17). Male db/db and its misty (m/m) normal mice (5 weeks of age) were purchased from Charles River Japan (Kanagawa, Japan). Animals were individually housed in stainless-steel cages with wire bottoms in an air-conditioned room with a temperature of 22 ± 2°C, a relative humidity of 60 ± 5 %, and an 8:00-20:00 light cycle. All mice were maintained on a stock CE-2 pellet diet (CLEA Japan, Tokyo), for 3 days and thereafter on a basal 20 % casein diet (20C) for 4 days. The composition of the 20C diet (AIN-93G formula) was described previously (Kawano et al. 2009 ). After preliminary feeding of CE-2 and 20C for 1 week, mice were deprived of their diet at 9:00 but allowed free access to water until blood collection from tail vein 3 h later. After determination of blood glucose concentrations with a commercial kit as described previously (Minakawa et al. 2011) , db/db mice were divided into three groups of similar fasting blood glucose (FBG) levels and body weights (0 week). Diabetic mice of each of the three groups were given either the 20C diet as the diabetic control (CNT) group, 20C diet supplemented with 0.001 % ENL (ENL-L) or 20C diet supplemented with 0.01 % ENL (ENL-H) for 6 weeks. Likewise, misty mice were given the 20C diet as the normal (NOR) group for 6 weeks. Water and each diet were given ad libitum except for the experiments to determine FBG levels, which were conducted every week 3 h after fasting. At the end of 6th week of feeding, blood for final FBG determination was collected from tail vein. Thereafter whole blood was collected from all mice by cardiac puncture under Somnopentyl anesthesia and serum samples were prepared. Serum glucose, insulin, TG and TBARS levels were determined with commercial kits. Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated from glucose and insulin concentrations; HOMA-IR = fasting glucose level (mg/dl) 9 fasting insulin level (ng/ml)/405 (Lee et al. 2010) .
Intraperitoneal glucose tolerance test
Intraperitoneal glucose tolerance test (IPGTT) was performed as described previously (Kawano et al. 2009 ) after the determination of FBG levels at the 5th week of feeding. Two (CNT and ENL-H) groups of db/db mice were deprived of their diets at 20:00 but allowed free access to water. After fasted for 15 h, ENL was orally given to mice of ENL-H group at a dose of 1 mg/ml of 0.1 % carboxymethyl cellulose sodium salt (CMC) solution/100 g body weight. Likewise, 0.1 % CMC solution alone (1 ml/100 g body weight) was orally given to mice of CNT group as a vehicle. Blood was collected from the tail vein of db/db mice 2 h later (0 min). Immediately after blood collection, diabetic mice received an intraperitoneal injection of glucose (0.2 g/ml/100 g body weight). Blood samples were successively collected at appropriate time intervals (30, 60, 90, 120 and 180 min) , and blood glucose levels were determined as previously described (Kawano et al. 2009 ).
Statistical analyses
Data are expressed as means ± standard errors of means (SEM). Multigroup comparisons were conducted by one-way analysis of variance followed by Tukey-Kramer multiple comparisons test and differences between two group means were compared by Student's t test. Values of p \ 0.05 were considered statistically significant.
Results
Effect of ENL on glucose uptake in cultured L6 myotubes
As shown in Fig. 1a , ENL dose-dependently and significantly increased glucose uptake in L6 myotubes at concentrations up to 100 lM in the absence of insulin. Compound C, an AMPK inhibitor (Zhou et al. 2001) , significantly canceled the ENL-induced promotion of glucose uptake at a concentration of 10 lM (Son et al. 2013) , where compound C alone exerted no influence on glucose uptake (Fig. 1b) . This result strongly suggested an involvement of AMPK in ENLstimulated glucose uptake.
Effect of ENL on phosphorylation of AMPK in cultured L6 myotubes L6 myotubes were treated with 50 lM of ENL for 30, 60, 120 and 240 min. The cells were also treated with AICAR (1 mM), a well-known activator of AMPK, for 30 min as a positive control agent (Fig. 1c) . ENL stimulated the phosphorylation of AMPK, that is, ENL raised the ratio of phosphorylated AMPK to AMPK, p-AMPK/AMPK, from 30 min after treatment, which peaked after 120 min (Fig. 1d) . These results suggested promotion by ENL of GLUT4 translocation to plasma membrane of L6 myocytes.
Effect of ENL on translocation of GLUT4 to plasma membrane of cultured L6 myocytes To explore regulatory mechanisms for promotion of glucose uptake by ENL, we determined the translocation of GLUT4, known as a main glucose transporter in the skeletal muscle system, by Western blotting. Na
-ATPase was employed as a plasma membrane marker (Fig. 2a) . ENL treatment of L6 myotubes for 30 min at 50 lM stimulated the translocation of GLUT4 to plasma membrane of L6 myotubes (Fig. 2a , upper electrophoretic profile). The ratio of GLUT4 to Na
-ATPase) significantly increased in ENL-treated cells (Fig. 2a, lower  graph) . Furthermore, the effect of ENL on GLUT4 translocation was visually confirmed by immunocytochemistry. We employed L6 myoblasts to transfect the expression vector (HaloTag Ò -glut4 vector), because transfection efficiency into L6 myotubes was very low (Minakawa et al. 2012) . Caveolin-3 is involved in spatial and temporal regulation of GLUT4 translocation to plasma membrane and hence glucose uptake in skeletal muscle cells (Fecchi et al. 2006) . Figure 2b (top, red) shows cellular localization of Halo-GLUT4 protein [GLUT4-ENL(-) and GLUT4-ENL(?)], Fig. 2b (center, green) shows cellular localization of caveolin-3, and Fig. 2b (bottom, yellowish) shows their merging. In the absence of ENL, Halo-GLUT4 protein and caveolin-3 were expressed in whole area and partially in the cell surface regions in L6 myoblast transfected with HaloTag Ò -glut4 vector as shown in Fig. 2b [left, ENL(-)]. ENL treatment at 50 lM for 30 min strengthened co-localization of GLUT4 protein and caveolin-3 in the plasma membrane compartment as shown by yellowish color in Fig. 2b [right, ENL(?)].
Effect of ENL on fasting blood glucose levels, insulin resistance, glucose intolerance and serum lipid levels in db/db mice Based on these in vitro findings, we successively studied in vivo effect of ENL on glucose metabolism employing severe type 2 diabetic model db/db mice. Food intake and body weight gain for 6 weeks are shown in Table 1 . Both of them were significantly higher in diabetic control mice than in normal mice (NOR vs. CNT). However, food intake and body weight gain were almost the same among three diabetic mice groups (CNT, ENL-L and ENL-H). The latter findings indicate that the action of ENL on glucose and lipid metabolism in mice described below is considered to be not due to reduced food consumption but due to biological effects of ENL. As shown in Fig. 3a , the FBG levels of diabetic control mice (CNT) increased up to the 2nd week of feeding and thereafter maintained the high FBG levels, while those of normal mice (NOR) were almost constant throughout the feeding period. Administration of ENL to db/db mice significantly suppressed at 1st, 3rd and 4th weeks after feeding and tended to suppress the FBG levels at 2nd, 5th and 6th weeks after feeding (CNT vs. ENL-L, CNT vs. ENL-H).
As depicted in Fig. 3b , HOMA-IR, an index of insulin resistance, was strikingly increased in diabetic mice as compared to that of normal mice (CNT vs. NOR). This rise in HOMA-IR was significantly suppressed by ENL administration (CNT vs. ENL-L, CNT vs. ENL-H). Figure 4 shows the results of IPGTT using mice of CNT and ENL-H groups. The blood glucose levels in diabetic control mice approximately linearly increased up to 120 min after intraperitoneal glucose administration, while ENL treatment significantly suppressed this rise 60, 90 and 120 min after glucose administration (Fig. 4a) . The area under the curve (AUC) was also significantly lower in the ENL-treated group than in the vehicle-treated CNT group (Fig. 4b) . Serum TBARS and TG levels were significantly higher in mice of CNT group than in those of NOR group. These rises were suppressed dose-dependently (TBARS, Fig. 5a ) or significantly (TG, Fig. 5b ) by the treatment of ENL.
Discussion
The skeletal muscle cells are one of the main sites of glucose uptake through GLUT4 in response to insulin. In muscle cells, AMPK is known as another GLUT4 translocation promoter. Natural compounds that activate AMPK have a possibility to overcome insulin resistance in the diabetic state (Yagasaki 2014) . Indeed, using cultured L6 myocytes, we have found food components and natural resources that activate AMPK, promote GLUT4 translocation to plasma membrane of myocytes and possess antidiabetic effects in T2D model animals; such as food components including aspalathin (Kawano et al. 2009; Son et al. 2013) , resveratrol (Minakawa et al. 2011) , piceatannol (Minakawa et al. 2012) , genistein (Ha et al. 2012) , daidzein (Cheong et al. 2014a) , equol (Cheong et al. 2014b) , nepodin (Ha et al. 2014) , gingerol and green rooibos extract (Kamakura et al. 2015) . Recently, urinary concentrations of lignan metabolites, especially ENL, are NOR normal m/m mice group, CNT control diabetic db/db mice group, ENL-L enterolactone-low dose (0.001 % in diet) group, ENL-H enterolactone-high dose (0.01 % in diet) group, ENL enterolactone reported to be significantly associated with a lower risk of T2D in humans (Sun et al. 2014) . In the present study, we studied the effect of ENL on glucose metabolism and its modes of action in cultured L6 myocytes and T2D model db/db mice.
In L6 myotubes, ENL dose-dependently and significantly promoted glucose uptake. This promotion by ENL was entirely eliminated by co-existing of compound C, an inhibitor of AMPK. This strongly suggested an involvement of AMPK in the promotive effect of ENL on glucose uptake. As was expected, AMPK was in fact activated (=phosphorylated) by ENL treatment. Activation of AMPK has emerged as the critical event that upregulates GLUT4 translocation to the plasma membrane independently of insulin (Krook et al. 2004 ). Thus, we tried to confirm whether or not ENL would promote GLUT4 translocation to plasma membrane of L6 myocytes by two procedures, Western blotting and immunocytochemistry. In L6 myotubes, ENL proved to promote GLUT4 translocation to plasma membrane by Western blotting. Furthermore, ENL treatment strengthened co-localization of GLUT4 protein and caveolin-3 in the plasma membrane region of L6 myoblasts transfected with HaloTag Ò -glut4 vector. These results visually verified that ENL did promote GLUT4 translocation to plasma membrane in L6 myoblasts, as previously demonstrated for the first time in piceatannol-treated L6 myoblasts as well as L6 myotubes (Minakawa et al. 2012) . Recently, resveratrol has been shown to directly inhibit cAMP-dependent phosphodiesterases (PDEs), leading to elevated cellular cAMP levels and resveratrol increases AMPK phosphorylation via involvement of Ca 2? through phospholipase C and the ryanodine receptor Ca 2? -release channel (Park et al. 2012 ). Hence, it seems worthy from the aspect of direct target identification to know if ENL could inhibit PDEs. In severe T2D model db/db mice, ENL suppressed hyperglycemia and improved the impaired glucose tolerance. ENL also suppressed the increases in serum TBARS and TG concentrations. Thus, ENL proved to ameliorate abnormal lipid metabolism as well as glucose metabolism in vivo.
In the present study, we could find ENL in the assay system in vitro as a novel antidiabetic molecule in cultured L6 myocytes and demonstrate its antidiabetic effect in vivo employing T2D model db/db mice. The most interesting and characteristic point in the present study is that effective dose (0.01 % in diet) of ENL in vivo is very low as previously reported in the antidiabetic effect of equol which significantly reduced hyperglycemia at a dose of 0.05 % in diet (Cheong et al. 2014b) . Equol has been known as a soybean isoflavone metabolite formed by intestinal bacteria from daidzin and daidzein like ENL from lignans (Rowland et al. 2000) . After ingestion, daidzein is converted to equol by the gut microflora. Thus, ENL and equol are intracorporeally formed after ingestion of lignans and isoflavones, respectively. These phenomena suggest that ENL and equol are main chemical entities showing antidiabetic actions and explain, at least partly, the reason for very low effective doses in their antidiabetic actions in vivo. Lignans are contained in many kinds of ordinary foods such as strawberry (Giampieri et al. 2012 (Giampieri et al. , 2014 and cereals (Bach Knudsen et al. 2003) and are suggested to possess various health beneficial effects including antidiabetic actions. Thus, studies on further detailed mechanisms for antidiabetic and other actions are required.
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